对乳腺癌治疗中新辅助化疗的研究趋势的可视化:一个文献计量分析
Tian Tian1, Chao Li1, Chao Hu1
1Department of General Surgery, Beijing Luhe Hospital, Capital Medical University, Beijing, 101149, China.
Discover oncology
|June 19, 2025
概括
本文献分析揭示了乳腺癌研究新辅助化疗 (NAC) 的关键趋势. 它确定了主要的贡献者,并突出了研究差距,特别是在三阴性乳腺癌 (TNBC) 中,敦促进行更多的合作试验.
科学领域:
- 在瘤学瘤学.
- 图书统计学 图书统计学
- 医疗信息学 医疗信息学
背景情况:
- 新辅助化疗 (NAC) 对于乳腺癌治疗至关重要,旨在在手术前减少瘤大小.
- 虽然乳腺癌的NAC研究正在增长,但缺乏全面的文献计量和临床分析.
- 本研究解决了对该领域的演变和关键贡献进行系统概述的需求.
研究的目的:
- 在乳腺癌研究中对新辅助化疗 (NAC) 进行文献分析.
- 识别有影响力的研究,作者和研究趋势.
- 为未来的研究方向提供见解,并识别知识缺口.
主要方法:
- 从1999年到2024年发表的11505篇文章的图书统计分析,来源于科学网络核心集合 (WoSCC).
- 使用VOSviewer,CiteSpace,以及用于数据分析的"bibliometrix"套件.
- 分析包括出版物数量,作者贡献,期刊影响力和关键词的同时出现.
主要成果:
- 美国在NAC乳腺癌研究中的出版物和有影响力的文章方面处于领先地位.
- 关键的研究人员包括Sibylle Loibl,Michael Untch和G. Von Minckwitz,Von Minckwitz是最常被引用的作者.
- 研究热点侧重于生存率,手术前化疗疗效和整体治疗策略,对三阴性乳腺癌 (TNBC) 的正电子发射断层扫描越来越感兴趣.
结论:
- 该研究绘制了NAC乳腺癌研究的格局,确定了关键参与者和不断发展的趋势.
- 确定的研究缺陷包括有限的国际合作和对像TNBC这样的侵略性亚型的治疗策略未经探索.
- 需要进行更多高质量的临床试验,以提高 NAC 乳腺癌的个性化治疗和反应预测.
更多相关视频
08:32Using Computer-based Image Analysis to Improve Quantification of Lung Metastasis in the 4T1 Breast Cancer Model
Published on: October 2, 2020
6.4K
07:41Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
9.1K
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Cancer Survival Analysis
458
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
458
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
